Home › Hansa Medical receives FDA Orphan Drug Designation for IdeS
 

Keywords :   


Hansa Medical receives FDA Orphan Drug Designation for IdeS

2015-09-15 06:06:51| Appliances - Topix.net

Hansa Medical today announced that the U.S. Food and Drug Administration has granted orphan drug designation to IdeS for the prevention of antibody mediated organ rejection in solid organ transplant patients. More information about the ODD has been posted on www.fda.com Approximately 30 percent of the patients on the waiting lists for kidney, heart, lung and pancreas, equivalent to approximately 35 000 patients in the US, are sensitized to Human Leukocyte Antigen .

Tags: medical drug receives designation

Category:Consumer Goods and Services

Latest from this category

All news
08.10China hits back at EU with brandy tax
08.10HS2 likely to reach Euston, signals minister
08.10Vodafone deepens strategic partnership with Google
08.10China stock rally fizzles as stimulus news disappoints
08.10China stock rally fizzles as stimulus news disappoints
08.10DishTV India offers satellite direct-to-TV with Nagra and Samsung
08.10Freely to be integrated into Amazon Fire TV smart TVs
08.10ADTH announces NextGen TV USB and app for Android and Fire TV
Consumer Goods and Services »
08.10China hits back at EU with brandy tax
08.10Wastewater Treatment Plants Sue PFAS Manufacturers
08.10WM Holds Ribbon Cutting Event for New Recycling Facility in Fort Walton Beach, Fla.
08.10City of Syracuse Beings Delivering New 96-Gallon Recycling Carts to Households
08.10Clemens Food Group to close Lancaster-based Kunzler & Company
08.10New Legacy Feed mill expands Keystones swine, animal nutrition into new territory
08.10Hurricane Milton Public Advisory Number 13A
08.10Summary for Hurricane Milton (AT4/AL142024)
More »